Leaders in Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:
Also, what is 7 + 8?

Good Medicine: Europe Set for $2 Billion of Investments in Fourth-Quarter 2016 Life Science Capital/MRO Project Starts

Good Medicine: Europe Set for $2 Billion of Investments in Fourth-Quarter 2016 Life Science Capital/MRO Project Starts


Attachment: Pharma-Biotech Europe Kickoffs 4Q16

SUGAR LAND--October 6, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As the North American Pharmaceutical-Biotech Industry, which includes coverage of pharmaceuticals, biologicals, medical devices and cosmetics, continues to return a healthy capital expenditures (capex) investment profile, Europe's volume of project activity continues to impress. During the last three months of 2016, more than $2 billion worth of projects are expected to launch construction on the continent.

Within this article: Details on some of the highest-valued projects set to begin construction in Europe's Pharmaceutical-Biotech Industry.